APVO   $0.2  25.00% Market Closed After Close 0.204 2.00%

Aptevo Therapeutics Inc
Total Cash 8.07M
totalCashPerShare 0.856
EBITDA -25.52M
Total Debt 5.72M
quickRatio 1.488
currentRatio 1.768
Total Revenue
debtToEquity 128.277
Revenue/Share
ROA -0.74004996
ROE -2.43734
grossProfits
freeCashflow -16.01M
operatingCashflow -24.30M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -975.97K
forwardPE -0.02607204
floatShares 8.89M
sharesOutstanding 13.44M
sharesShort 58.35K
sharesShortPriorMonth 61.43K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.15%
Short Ratio help_outline 0.02%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 1.094
Price To Book help_outline 0.14
earningsQuarterlyGrowth
netIncomeToCommon -25.25M
trailingEps -35.64%
forwardEps -5.83%
enterpriseToEbitda 0.04
lastDividendValue
lastDividendDate
currentQuarterEstimate -3.35 3Q 2024
institutionsCount 20
lastUpdated Oct. 16, 2024, 6:48 p.m.